Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer.
Autolus Therapeutics stock last closed at $1.31, down 5.76% from the previous day, and has decreased 65.53% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Autolus Therapeutics stock is currently +18.55% from its 52-week low of $1.11, and -73.8% from its 52-week high of $5.00.
As of Apr 29, 2025, there are 266.13M shares of AUTL outstanding. The market value of AUTL is $348.63M. In the past 24 hours, 2.16M AUTL shares were traded.
How to Buy Autolus Therapeutics Stock
Not sure how to invest in Autolus Therapeutics stock? Here's how.
Decide where to buy Autolus Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Autolus Therapeutics stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Pick your payment method and add your information.
Research Autolus Therapeutics stock: The Autolus Therapeutics ticker symbol is AUTL. Is Autolus Therapeutics stock a good investment? Should you buy shares of AUTL? How do AUTL's underlying business fundamentals look? Do top analysts think Autolus Therapeutics is a good buy? Why has AUTL's stock price moved recently? (Hint: Our stock market research website can help you understand if AUTL is a good stock to buy).
Place your AUTL purchase: Decide if you will purchase AUTL shares at the current market price or use a limit order to buy AUTL shares at a given price.
Monitor your AUTL investment: Create a watchlist to important updates regarding your new investment in Autolus Therapeutics stock.
Step 1: Decide where to buy Autolus Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy AUTL stock.
A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in AUTL stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Autolus Therapeutics stock
Once you have decided on the best place to buy Autolus Therapeutics stock, it's critical to analyze their stock prior to buying, so you truly understand the risk and upside.
Autolus Therapeutics stock data
AUTL Price
$1.31
1w %
-18.13%
1y %
-65.53%
5y %
-86.77%
P/E
-1.52x
P/B
0.82x
P/S
32.75x
PEG
N/A
Revenue
$10.12M
Earnings
-$220.66M
Fore. Rev. Growth
203.7%
Fore. Earn. Growth
N/A
Market Cap
$348.63M
Next Earnings
N/A
Next Dividend
N/A
AUTL Due Diligence Score
WallStreetZen was created to help part-time investors perform better fundamental analysis in minutes instead of hours.
Last year, AUTL revenue was $10.12M. During the past five year, AUTL's revenue has grown by 28.33% per year. This was slower than the Biotechnology industry average of 45.47%.
No, Autolus Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about AUTL?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your AUTL purchase
You have two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually fine for most investors.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.
Click the Open Trade button and eToro will place your order.
If you want additional info about buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Autolus Therapeutics share?
As of Apr 29, 2025, it costs $1.31 to buy one share of Autolus Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.66, you can buy 0.5 shares of AUTL.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.